Delivery Order SPE2DB22D3102-SPE2DB25FL1ZA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $14,722.52. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $1,845.62 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine syringes (0.5mL) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within the company's broader pharmaceutical supply relationship with DLA. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $13,446.66 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringe format, valued at $5,119.60. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by November 10, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,435.48 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe format (0.5mL). This non-set-aside contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a firm fixed-price delivery order. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a key distribution hub for the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,330.45 to supply Boostrix Tdap vaccine in 0.5ML syringe format. This competitively awarded, firm fixed-price delivery order is set to conclude on October 27, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The contract represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and supports the Defense Logistics...
- The Defense Logistics Agency awarded a $16,986.52 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract includes no set-aside designation and was competitively awarded through open procurement channels. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $52,873.75 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, competitively awarded delivery order has an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price contract carries a ceiling value of $2,053.23 and an ultimate completion date of October 22, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,342.46 for Boostrix TDAP vaccine in 0.5mL syringe format on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL1ZADelivery Order
The Defense Logistics Agency awarded a $1,330.50 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price, non-set-aside contract with a completion date of June 26, 2025, and the work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement through DLA's medical supply chain to support federal healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in federal medical procurement through its competitive awards with DLA and serves critical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/25/25 |